🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: inactivated non adjuvanted pandemic H1N1 vaccine

Found 14 matching trials

Safety and Efficacy of an Inactivated and Non Adjuvanted Vaccine Against Influenza A in Renal Transplant Recipients

PHASE2

The study is aimed at assessing the safety and efficacy of an inactivated a...

Status

Completed

Location

Centre hospitalier Lyon Sud, service de néphrologie transplantation

Start Date

2009-11

Trial ID

NCT01086904

Treatments Being Tested

inactivated non adjuvanted pandemic H1N1 vaccine

Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients

PHASE2

The 2009 flu pandemic is a global outbreak of a new strain of influenza A v...

Status

Unknown

Location

Shanghai Public Health Clinical Center

Start Date

2009-10

Trial ID

NCT01055990

Treatments Being Tested

split-virion, non-adjuvanted H1N1 vaccine of 15 μg blood fix

Immunogenicity, Tolerability and Safety of One or Two Doses of an Adjuvanted Swine-origin A H1N1 Influenza Vaccine in Healthy Subjects 18 or More Years of Age Both Vaccinated and Not Yet Vaccinated Against Seasonal Influenza 2009/10

PHASE2

This present study, a phase II, open label study will evaluate the immunoge...

Status

Completed

Location

Start Date

2009-08

Trial ID

NCT00992212

Treatments Being Tested

Monovalent A/H1N1 influenza vaccine

Evaluation of Pandemic Influenza A (H1N1) Vaccine in Chronic and or Immunocompromised Patients, Elderly and Pregnants

N/A

The objective of this study is to describe the safety and immunogenicity of...

Status

Completed

Location

Avenida Vital Brasil 1500

Start Date

2010-04

Trial ID

NCT01218685

Treatments Being Tested

Split inactivated A/California/7/2009 (H1N1) (NYMC X-179A) VIRUS

The Long-term Immunogenicity of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine

PHASE2

The aim of this study is to investigate the long-term immunogenicity and sa...

Status

Completed

Location

Hunan Provincial Center of Disease Prevention and Control

Start Date

2009-07

Trial ID

NCT01336166

Treatments Being Tested

split-virion, non-adjuvanted H1N1 vaccine of 15 μg split-virion, non-adjuvanted H1N1 vaccine of 30 μg split-virion, non-adjuvanted H1N1 vaccine of 45 μg Placebo control

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects From 6 Months to 17 Years of Age

PHASE3

The present study, randomized, single-blind, dose-ranging, multicenter stud...

Status

Completed

Location

Multiple Locations

Start Date

2009-08

Trial ID

NCT00971100

Treatments Being Tested

Monovalent A/H1N1 influenza vaccine

Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in Infants

PHASE2

The aim of this study is to investigate the immunogenicity and safety of th...

Status

Completed

Location

Hunan Provincial Center of Disease Prevention and Control Changsha, Hunan, China

Start Date

2009-12

Trial ID

NCT01494740

Treatments Being Tested

split-virion, non-adjuvanted vaccine of 7.5 μg split-virion, non-adjuvanted H1N1 vaccine of 15 μg split-virion, non-adjuvanted vaccine of seasonal influenza

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age

PHASE3

This present study, randomized, single-blind, dose-ranging, multicenter stu...

Status

Completed

Location

Multiple Locations

Start Date

2009-08

Trial ID

NCT00970177

Treatments Being Tested

Monovalent A/H1N1 influenza vaccine

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine (Egg-Derived) in Healthy Subjects From 6 Months to 17 Years of Age

PHASE3

The present study, randomized, single-blind, dose-ranging, multicenter stud...

Status

Completed

Location

Multiple Locations

Start Date

2009-09

Trial ID

NCT00971542

Treatments Being Tested

Monovalent A/H1N1 influenza vaccine

Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age

PHASE3

This present study, randomized, single-blind, dose-ranging, multicenter stu...

Status

Completed

Location

Gent, Antwerpen

Start Date

2009-08

Trial ID

NCT00971906

Treatments Being Tested

Monovalent A/H1N1 influenza vaccine

Previous Next